Westendorf JJ - Search Results

1

Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression.

Jelinek DF, Aagaard-Tillery KM, Arendt BK, Arora T, Tschumper RC, Westendorf JJ. Jelinek DF, et al. Among authors: westendorf jj. J Clin Invest. 1997 Feb 1;99(3):447-56. doi: 10.1172/JCI119179. J Clin Invest. 1997. PMID: 9022078 Free PMC article.

2

CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.

Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF. Westendorf JJ, et al. J Immunol. 1994 Jan 1;152(1):117-28. J Immunol. 1994. PMID: 7504707

3

Molecular and biological role of CD40 in multiple myeloma.

Westendorf JJ, Ahmann GJ, Lust JA, Tschumper RC, Greipp PR, Katzmann JA, Jelinek DF. Westendorf JJ, et al. Curr Top Microbiol Immunol. 1995;194:63-72. doi: 10.1007/978-3-642-79275-5_9. Curr Top Microbiol Immunol. 1995. PMID: 7534674 No abstract available.

4

Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines.

Westendorf JJ, Lammert JM, Jelinek DF. Westendorf JJ, et al. Blood. 1995 Jun 15;85(12):3566-76. Blood. 1995. PMID: 7540067 Free article.

5

Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.

Jelinek DF, Ahmann GJ, Greipp PR, Jalal SM, Westendorf JJ, Katzmann JA, Kyle RA, Lust JA. Jelinek DF, et al. Among authors: westendorf jj. Cancer Res. 1993 Nov 1;53(21):5320-7. Cancer Res. 1993. PMID: 8221668

6

Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.

Westendorf JJ, Ahmann GJ, Greipp PR, Witzig TE, Lust JA, Jelinek DF. Westendorf JJ, et al. Leukemia. 1996 May;10(5):866-76. Leukemia. 1996. PMID: 8656685

7

Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.

Westendorf JJ, Jelinek DF. Westendorf JJ, et al. J Immunol. 1996 Oct 1;157(7):3081-8. J Immunol. 1996. PMID: 8816418

8

Building bone to reverse osteoporosis and repair fractures.

Khosla S, Westendorf JJ, Oursler MJ. Khosla S, et al. Among authors: westendorf jj. J Clin Invest. 2008 Feb;118(2):421-8. doi: 10.1172/JCI33612. J Clin Invest. 2008. PMID: 18246192 Free PMC article. Review.

9

Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.

Kahler RA, Westendorf JJ. Kahler RA, et al. Among authors: westendorf jj. J Biol Chem. 2003 Apr 4;278(14):11937-44. doi: 10.1074/jbc.M211443200. Epub 2003 Jan 27. J Biol Chem. 2003. PMID: 12551949 Free article.

10

Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.

Li X, Hoeppner LH, Jensen ED, Gopalakrishnan R, Westendorf JJ. Li X, et al. Among authors: westendorf jj. J Cell Biochem. 2009 Oct 1;108(2):378-87. doi: 10.1002/jcb.22263. J Cell Biochem. 2009. PMID: 19585539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters